Zobrazeno 1 - 10
of 494
pro vyhledávání: '"Yoshiyuki, Yamamoto"'
Autor:
Tadayoshi Hashimoto, Yoshiaki Nakamura, Yoshito Komatsu, Satoshi Yuki, Naoki Takahashi, Naohiro Okano, Hidekazu Hirano, Koushiro Ohtsubo, Takashi Ohta, Eiji Oki, Tomohiro Nishina, Hisateru Yasui, Hisato Kawakami, Taito Esaki, Nozomu Machida, Ayako Doi, Shogen Boku, Toshihiro Kudo, Yoshiyuki Yamamoto, Akiyoshi Kanazawa, Tadamichi Denda, Masahiro Goto, Naoko Iida, Hiroshi Ozaki, Taro Shibuki, Mitsuho Imai, Takao Fujisawa, Hideaki Bando, Yoichi Naito, Takayuki Yoshino
Publikováno v:
BJC Reports, Vol 2, Iss 1, Pp 1-10 (2024)
Abstract Background While advanced gastrointestinal stromal tumors (GISTs) are primarily treated with tyrosine kinase inhibitors (TKIs), acquired resistance from specific mutations in KIT or PDGFRA frequently occurs. We aimed to assess the utility of
Externí odkaz:
https://doaj.org/article/8d89e02235024fa88d2552871e8438cb
Autor:
Kohei Segawa, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Yoichi Kakuta, Atsunari Kawashima, Shinichiro Fukuhara, Norio Nonomura
Publikováno v:
IJU Case Reports, Vol 7, Iss 4, Pp 336-340 (2024)
Introduction Neurofibromatosis type 1 is a hereditary condition often associated with pheochromocytomas but rarely with malignant pheochromocytomas. Neurofibromatosis type 1 is often associated with bone lesions, which complicates the distinction bet
Externí odkaz:
https://doaj.org/article/785e9677ce644c5099da757b2e5aa767
Autor:
Masaru Tani, Koji Hatano, Akihiro Yoshimura, Yuki Horibe, Yutong Liu, Nesrine Sassi, Toshiki Oka, Yohei Okuda, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Atsunari Kawashima, Norio Nonomura
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Bone-modifying agents (BMA) are extensively used in treating patients with prostate cancer with bone metastases. However, this increases the risk of medication-related osteonecrosis of the jaw (MRONJ). The safety of long-term BMA administrat
Externí odkaz:
https://doaj.org/article/fc2b4f95788741b2a0b97445519c779c
Autor:
Taigo Kato, Koichi Morishita, Eisuke Tomiyama, Ayumu Hayashibara, Yu Ishizuya, Yoshiyuki Yamamoto, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Norio Nonomura, Eiji Miyoshi, Kazutoshi Fujita
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract With the widespread use of immune checkpoint inhibitors (ICIs), identifying predictive biomarkers is critical. Recently, serum fucosylated haptoglobin (Fuc-Hp) was thought to play an important role in tumour immunity in several types of canc
Externí odkaz:
https://doaj.org/article/c23cff85f5824bf88fa6a762802954b6
Autor:
Osamu Shimomura, Masato Endo, Hirokazu Makishima, Takeshi Yamada, Shinji Hashimoto, Haruko Numajiri, Yoshihiro Miyazaki, Manami Doi, Kinji Furuya, Kazuhiro Takahashi, Toshikazu Moriwaki, Naoyuki Hasegawa, Yoshiyuki Yamamoto, Yusuke Niisato, Mariko Kobayashi, Masashi Mizumoto, Kei Nakai, Takashi Saito, Sodai Hoshiai, Tsukasa Saida, Bryan J. Mathis, Kensaku Mori, Takahito Nakajima, Kiichiro Tsuchiya, Hideyuki Sakurai, Tatsuya Oda
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Locally advanced pancreatic ductal adenocarcinoma (PDAC), accounting for about 30% of PDAC patients, is difficult to cure by radical resection or systemic chemotherapy alone. A multidisciplinary strategy is required and our TT-LAP
Externí odkaz:
https://doaj.org/article/3a9e7b2055814ea4bcf6be5edfcd70ff
Autor:
Takahiro Maekawa, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Atsunari Kawashima, Shinichiro Fukuhara, Ryoichi Imamura, Norio Nonomura
Publikováno v:
IJU Case Reports, Vol 6, Iss 4, Pp 257-261 (2023)
Introduction Liposarcoma is the most common retroperitoneal soft tissue tumor. Liposarcomas are often asymptomatic and are discovered after they become huge. Surgical resection is the first‐line treatment for retroperitoneal liposarcoma, but the su
Externí odkaz:
https://doaj.org/article/115170e34e24446db121b2b27a436f24
Autor:
Naoki Takahashi, Hirokazu Shoji, Kengo Nagashima, Hiroshi Imazeki, Narikazu Boku, Takeshi Kawakami, Kei Muro, Takeru Wakatsuki, Chie Kudo-Saito, Yukiya Narita, Kai Tsugaru, Yusuke Amanuma, Naohiro Okano, Yoshiyuki Yamamoto, Rika Kizawa, Kazunori Aoki
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/907a904781714c80bf6d47dac396da55
Autor:
Toshihiro Uemura, Atsunari Kawashima, Kentaro Jingushi, Daisuke Motooka, Takuro Saito, Sassi Nesrine, Toshiki Oka, Yohei Okuda, Akinaru Yamamoto, Gaku Yamamichi, Eisuke Tomiyama, Yu Ishizuya, Yoshiyuki Yamamoto, Taigo Kato, Koji Hatano, Kazutake Tsujikawa, Hisashi Wada, Norio Nonomura
Publikováno v:
Heliyon, Vol 9, Iss 9, Pp e19800- (2023)
This is the first study to determine the clinical importance of circulating bacterial DNA in patients with renal cell carcinoma (RCC). We performed 16S rRNA metagenomic analysis of serum extracellular vesicles (EVs) from 88 patients with RCC and 10 h
Externí odkaz:
https://doaj.org/article/773d78540e4440d9b22b02288d314b51
Autor:
Hidehiko Nemoto, Kensaku Mori, Yohei Takei, Shunsuke Kikuchi, Sodai Hoshiai, Yoshiyuki Yamamoto, Takahito Nakajima
Publikováno v:
CVIR Endovascular, Vol 5, Iss 1, Pp 1-5 (2022)
Abstract Background Superior rectal artery (SRA) aneurysms are rare. Although melena is the most common symptom, it has not been observed in cases of aneurysms located in the SRA trunk. Here, we report a case of a ruptured SRA trunk aneurysm successf
Externí odkaz:
https://doaj.org/article/e3f292f2ff0e4e29af31825767c5bb7e
Autor:
Yoshiyuki Yamamoto, MD, PhD, Atsunari Kawashima, MD, PhD, Toshitaka Morishima, MD, PhD, Toshihiro Uemura, MD, Akinaru Yamamoto, MD, Gaku Yamamichi, MD, Eisuke Tomiyama, MD, Makoto Matsushita, MD, PhD, Taigo Kato, MD, PhD, Koji Hatano, MD, PhD, Isao Miyashiro, MD, PhD, Norio Nonomura, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 3, Pp 101157- (2023)
Purpose: Radical cystectomy (RC) with neoadjuvant chemotherapy is the most commonly recommended treatment for muscle-invasive bladder cancer (MIBC), yet RC with urinary diversion remains an invasive treatment. Although some patients with MIBC gain go
Externí odkaz:
https://doaj.org/article/68cb5efd97ce497ab7e4c579e823a93a